Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism

Biochimie

Volumn 79, Issue 2-3, 1997, Pages 81-94

  Latruffe, N ^a   Vamecq, J ^b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b INSERM   (France)

Author keywords

Adipogenesis; Lipid metabolism; Peroxisome proliferator; PPARs

Indexed keywords

ACYL COENZYME A OXIDASE; CELL NUCLEUS RECEPTOR; FATTY ACID; HEAT SHOCK PROTEIN; LEUKOTRIENE B4; LIGAND; LIPID; LIPOPROTEIN; PEROXISOME PROLIFERATOR; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN J2; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE EXPRESSION REGULATION; KETOGENESIS; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER METABOLISM; METABOLIC REGULATION; MOLECULAR CLONING; PEROXISOME; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0030841936     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(97)81496-4     Document Type: Article

References (162)

1. Hess R, Staubli W, Riess W (1965) Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 208, 856-858
2. Svoboda D, Azarnoff D (1966) Response of hepatic microbodies to hypolipidemic agent, ethyl chlorophenoxy isobutyrate (CPIB). J Cell Biol 30, 442-450
3. de Duve C (1965) Functions of microbodies (peroxisomes). J Cell Biol 27, 25-26
4. Baudhuin P, Beaufay H, de Duve C (1965) Combined biochemical and morphological study of particles fractions from rat liver. J Cell Biol 26, 219-243
5. Rhodin J (1954) In: Correlation of ultrastructural organisation and function in normal and experimentally changed convoluted tubule cells of the mouse kidney. PhD Thesis, Stockholm, Aktiebolaget Godvil
6. de Duve C (1969) Introductory remarks. Ann NY Acad Sci 168, 211-213
7. de Duve C (1969) Evolution of the peroxisome. Ann NY Acad Sci 168, 369-381
8. Cooper TG, Beevers H (1969) β-oxidation in glyoxysomes from castor bean endosperm. J Biol Chem 244, 3514-3520
9. Beevers H (1969) Glyoxysomes of castor bean endosperm and their relation to gluconeogenesis. Ann NY Acad Sci 168, 313-324
10. Lazarow PB, de Duve C (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 73, 2043-2046
11. Hawkins JM, Jones WE, Bonner FW, Gibson GG (1987) The effect of peroxisome proliferators on microsomal and mitochondrial activities in the liver and kidney. Drug Metab Rev 18, 441-515
12. Vamecq J, Draye JP (1989) Pathophysiology of peroxisomal β-oxidation. Essays Biochem 24, 115-225
13. Mannaerts GP, Debeer LJ, Thomas J, De Schepper PJ (1979) Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. J Biol Chem 254, 4585-4595
14. Lazarow PB, Shio H, Leroy-Houyet MA (1982) Specificity in the action of hypolipidemic drugs: increase of peroxisome beta-oxidation largely dissociated from hepatomegaly and peroxisoma proliferation in the rat. J Lipid Res 23, 317-326
15. Harrison EH (1984) Action of clofibrate and its analogs in rats. Dissociation of hypolipidemic effects and the induction of peroxisomal beta oxidation. Biochim Biophys Acta 796, 163-168
16. Issemann I, Green S (1990) Activation of a member of the steroid receptor superfamily by peroxisome proliferators. Nature 347, 645-650
17. Osumi T, Hijikata M, Ishii N, Miyazawa S, Hashimoto T (1987) Cloning and structural analysis of the gene for peroxisomal β-oxidation enzymes. In: Peroxisomes in Biology and Medicine (Fahimi HD, Sies H, eds) Springer Verlag, Berlin, Heidelberg, 105-114
18. Lalwani ND, Alvares K, Reddy MK, Reddy MN, Parish I, Reddy JK (1987) Peroxisome proliferator-binding protein: identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liver. Proc Natl Acad Sci USA 84, 5242-5246
19. Milton MN, Elcombe CR, Kass GEN, Gibson GG (1988) Lack of evidence for a hepatic peroxisome proliferator receptor and an explanation for the binding of hypolipidemic drugs to liver homogenates. Biochem Pharmacol 37, 793-798
20. Alvares K, Alejandro C, Yuan PM, Kawano H, Morimoto RI, Reddy JK (1990) Identification of cytosolic peroxisome proliferator binding protein as a member of the heat shock protein HSP-70 family. Proc Natl Acad Sci USA 87, 5293-5297
21. Kastner P, Mark M, Chambon P (1995) Non steroid nuclear receptors: what are genetic studies telling us about their role in real life. Cell 83, 859-869
22. Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83, 841-850
23. Mangelsdorf DJ, Thummel C, Beato M, Herllich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839
24. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Whali W (1992) Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879-887
25. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM (1994) mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8, 1224-1294
26. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM (1994) Differential expression and activation of a family of peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91, 7355-7359
27. Göttlicher M, Widmark E, Li Q, Gustafsson J (1992) Fatty acids activate a chimera of clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 89, 4653-4657
28. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA (1992) Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 6, 1634-1641
29. Sher T, Yi H, Mc Bride W, Gonzalez FJ (1993) cDNA cloning, chromosomal mapping, and functionnal characterization of the human PPARα. Biochemistry 32, 5598-5604
30. Zhu YJ, Alvares K, Huang Q, Rao MS, Reddy JK (1993) Cloning of a new member of the PPAR gene family from mouse liver. J Biol Chem 268, 26817-26820
31. Aperlo C, Pognonec P, Saladin R, Auwerx J, Boulukos KE (1995) cDNA cloning and characterization of the transcriptional activities of the hamster peroxisome proliferator-activated receptor ha PPAR gamma. Gene 162, 297-302
32. Seldin MF, Corton JC (1994) Mapping the peroxisome proliferator-activated receptor to chromosome 15 in the mouse. Mammalian Genome 5, 193-194
33. Beck F, Plummer S, Senior PV, Byrne S, Green S, Brammar WJ (1992) The ontogeny of peroxisome proliferator-activated receptor gene expression in the mouse and rat. Proc Roy Soc London B 247, 83-87
34. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W (1996) Differential expression of the peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPARα, -β and γ in the adult rat. Endocrinology 137, 354-366
35. Sears IB, Macginnitie MA, Kovacs LG, Groves RA (1996) Differentiation-dependent expression of the brown adipose uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma. Mol Cell Biol 16, 3410-3419
36. Varanasi U, Chu R, Huang Q, Castellon R, Yeldani A, Reddy JK (1995) Identification of a peroxisome proliferator responsive elements upstream of the human fatty acyl coenzyme A oxidase gene. J Biol Chem 271, 2147-2155
37. Berthou L, Saladin R, Yagoob P, Branellec D, Calder P, Fruchart JC, Denefle P, Auwerx J, Staels B (1995) Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids. Eur J Biochem 232, 179-187
38. Lambe KG, Tugwood D (1996) A human peroxisome proliferator-activated receptor γ is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 239, 1-7
39. Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RH, Weinberger C (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 88, 687-693
40. Amri EZ, Bonino F, Ailhaud G, Abumrad NA, Grimaldi PA (1995) Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptor. J Biol Chem 270, 2367-2371
41. Osumi T, Wen JK, Hashimoto T (1991) Two cis-acting regulatory sequences in the peroxisome proliferators-responsive enhancer region of rat acyl-CoA oxidase gene. Biochem Biophys Res Commun 175, 866-871
42. Tugwood JT, Issemann I, Anderson RG, Bundell K, Mc Pheat W, Green S (1992) The mouse peroxisome proliferator receptor recognizes a response element in the 5́ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11, 433-439
43. Issemann I, Prince RA, Tugwood JD, Green S (1993) The RXR enhances the function of the PPAR. Biochimie 75, 251-256
44. Issemann I, Prince RA, Tugwood JD, Green S (1992) A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation. Biochem Soc Trans 20, 824-827
45. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 358, 771-774
46. Muerhoff AS, Griffin KJ, Johnson EF (1992) The peroxisome proliferator-activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid w-hydroxylase, by clofibric acid. J Biol Chem 261, 19051-19053
47. Zhang B, Marcus SL, Sajjadi FG, Alvares K, Reddy JK, Subramani S, Rachubinski RA, Capone JP Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. Proc Natl Acad Sci USA 89, 7541-7545
48. Bardot O, Aldridge TC, Latruffe N, Green S (1993) PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun 192, 37-45
49. Baes M, Castelein H, Declerq PE (1994) The malic enzyme promoter contains multiple recognition sites for nuclear hormone recptors. J Cell Biochem 18B, 361
50. Rodriguez JC, Gomez GG, Hegardt FG, Haro D (1994) Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl synthase gene by fatty acids. J Biol Chem 269, 18767-18772
51. Keller HG, Wahli W (1993) Peroxisome proliferator-activated receptors: a link between endocrinology and nutrition. TEM 4, 291-296
52. Causeret C, Bentejac M, Bugaut M (1993) Proteins and enzymes of the peroxisomal membrane in mammals. Biol Cell 11, 89-104
53. Varanasi U, Chu R, Chu S, Espinosa R, Le Beau MM, Reddy JK (1994) Isolation of the human peroxisomal acyl-CoA oxidase gene: organisation, promoter analysis, and chromosomal localization. Proc Natl Acad Sci USA 91, 3107-3111
54. Motojima K, Goto S, Imanaka T. (1992) Specific repression of transthyretin gene expression in rat liver by peroxisome proliferator clofibrate. Biochem Biophys Res Commun 188, 799-806
55. Staels B, van Tol A, Andreu T, Auwerx J (1992) Fibrates influence the expression of the genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Artheroscl Thromb 12, 286-294
56. Staels B, Peinado-Onsurbe J, Auwerx J (1992) Down-regulation of hepatic lipase gene expression and activity by fenofibrate. Biochim Biophys Acta 1123, 227-230
57. Staels B, van Tol A, Skretting G, Auwerx J (1992) Lecithin: cholesterol acyltransferase gene expression is regulated in a tissue-selective manner by fibrates. J Lipid Res 33, 727-735
58. Motojima K, Isaka M, Takino Y, Goto S (1994) Transient induction of fatty acid synthase in rat liver after removal of a peroxisome proliferator. FEBS Lett 356, 122-124
59. Ren B, Thelen A, Jump DB (1996) Peroxisome proliferator-activated receptor a inhibits hepatic S14 gene transcription. J Biol Chem 271, 17167-17173
60. Motojima K (1993) Peroxisome proliferator-activated receptor (PPAR): structure, mechanisms of activation and diverse functions. Cell Struct Funct 18, 267-277
61. Vu Dac N, Schoonjans K, Laine B, Fruchard JC, Auwerx J, Staels B (1995) Negative regulation of the human apolipoprotein A1 promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem 269, 31012-31018
62. Hertz R, Bishara-Shieban J, Bar-Tana J (1995) Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J Biol Chem 270, 13470-13475
63. Staels B, Vu Dac N, Kosykh VA, Saldin R, Fruchart JC, Dallongeville J, Auwerx J (1995) Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl-coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J Clin Invest 95, 705-712
64. Wahli N, Braissant O, Desvergne B (1995) Peroxisome proliferator-activated receptor: transcriptional regulators of adipogenesis, lipid metabolism and more. Curr Biol 2, 261-266
65. Schoonjans K, Staels B, Auwerx J (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effect of fibrates and fatty acids on gene expression. J Lipid Res 37, 907-925
66. Desvergne B, Wahli W (1995) PPAR: a key nuclear factor in nutrient/gene interactions? In: Inducible gene expression (Baeuerle PA, ed) Birkhäuser, Boston, 142-176
67. Nunez SB, Medin JA, Keller M, Wang K, Ozato K, Wahli W, Segars J (1995) Retinoid X receptor beta and peroxisome proliferator-activated receptor activate an estrogen response element. Rec Progr Horm Res 50, 409-416
68. Chu R, Lin Y, Rao MS, Reddy JK (1995) Cooperative formation of higher order peroxisome proliferator-activated receptor and retinoid X receptor complexes on the peroxisome proliferator responsive element of the rat hydratase-dehydrogenase gene. J Biol Chem 270, 29636-29639
69. Miyata KS, Zhang B, Marcus SL, Capone JP, Rachubinski RA (1993) Chicken ovalbumine upstream promotor-transcription factor (COUP-TF) binds to a peroxisome proliferator responsive element and antagonizes peroxisome proliferator-mediated signaling pathway. J Biol Chem 268, 19169-19172
70. Rodriguez, JC, Hegardt FG, Haro D (1995) COUP-TF1 dependent repression of mitochondrial HMG-CoA synthase transactivation by the peroxisome proliferator-activated receptor. In: Peroxisomes, Biology and Role in Toxicology and Disease Symposium. Aspen Co & Ann NY Acad Sci, in press
71. Marcus SL, Capone JP, Rachubinski RA (1996) Identification of COUP-TFII as a peroxisome proliferator response element binding factor using genetic selection in yeast: COUP-TFII activates transcription in yeast but antagonizes PPAR signaling in mammalian cells. Mol Cell Endocrinol 120, 31-39
72. Palmer CNA, Hsu HH, Muerhoff AS, Griffin KJ, Johnson EF (1994) Interaction of the peroxisome proliferator-activated receptor a with the retinoid X receptor a unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1 binding site in the AFP4A6 promotor. J Biol Chem 269, 18083-18089
73. Winrow CG, Marcus SL, Miyata KS, Chang B, Capone JP, Rachubinski RA (1994) Transactivation of the peroxisome proliferator-activated receptor is differentially modulated by hepatocyte nuclear factor 4. Gene Expression 4, 53-62
74. Bogazzi F, Hudson LD, Nikodem VM (1994) A novel heterodimerization partner for thyroid hormone receptor. J Biol Chem 269, 11683-11686
75. Juge-Aubry CE, Gorla-Bajszczak A, Pernin A, Lemberger T, Wahli W, Burger AG, Meier CA (1995) Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. J Biol Chem 270, 18117-18122
76. Chu R, Madison LD, Lin Y, Kopp P, Rao MS, Jameson JL, Reddy JK (1995) Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding β-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways. Proc Natl Acad Sci USA 92, 11593-11597
77. Teboul L, Gaillard D, Staccini L, Inadera H, Amri EZ, Grimaldi PA (1995) Thiazolidinediones and fatty acids convert myogenic cells into adipose like cells. J Biol Chem 270, 28183-28187
78. Hunter J, Kassam A, Winrow CJ, Rachubinski RA, Capone JP (1996) Crosstalk between the thyroid hormone and peroxisome proliferated activated receptors in regulating peroxisome proliferator-responsive genes. Mol Cell Endocrinol 116, 213-221
79. Sakai M, Matsushimahimahibiya Y, Nishizawa M, Nishi S (1995) Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between jun and peroxisome proliferator-activated receptor alpha. Cancer Res 55, 5370-5376
80. Krey G, Mahfoudi A, Wahli W (1995) Functional interactions of peroxisome proliferator-activated receptor, retinoid X receptor and Sp1 in the transcriptional regulation of the acyl-coenzyme A oxidase promotor. Mol Endocrinol 9, 219-231
81. Miyata KS, McCaw SE, Patel HV, Rachubinski RA, Capone JP (1996) The orphan nuclear hormone receptor LXRa interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J Biol Chem 271, 9189-9122
82. Tontonoz P, Graves RA, Budavari AJ, Erdjument-Bromage M, Lui M, Hu E, Tempst P, Spiegelman BM (1995) Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors PPARγ and RXRα. Nucleic Acids Res 22, 5628-5634
83. Dreyer C, Keller H, Mahfoudi A, Laudet V, Krey G, Walhi W (1993). Positive regulation of the peroxisomal β-oxidation pathway by fatty acids through activation of the peroxisome proliferator-activated receptor (PPAR). Biol Cell 77, 67-76
84. Issemann I, Prince RA, Tugwood JT, Green S (1993) The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol 11, 37-49
85. Yu K, Bayona N, Kallen CB, Harding HP, Ravera CP, Mc Mahon G, Brown M, Lazar MA (1995) Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 270, 23975-23983
86. Boie Y, Adam M, Rushmore TM, Kennedy BP (1993) Enantioselective activation of the peroxisome proliferator-activated receptor. J Biol Chem 268, 5530-5534
87. Hertz R, Berman I, Keppler D, Bar Tana J (1996) Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome proliferator-activated receptor (PPAR). Eur J Biochem 235, 242-247
88. 13,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812
89. Poellinger L, Gotticher M, Gustafsson JA (1992) The dioxin and peroxisome proliferator-activated receptors: nuclear receptors in search of endogenous ligands (review). Trends Pharmacol Sci 13, 241-245
90. Göttlicher M, Demoz A, Svensson D, Tollet P, Berge RK, Gustafsson JA (1993) Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor. Biochem Pharmacol 46, 2177-2184
91. Banner CD, Gottlicher M, Widmark E, Sjovall J, Rafter JJ, Gustafsson JA (1993) A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts - characterization of peroxisome proliferator-activated receptor activators in plasma. J Lipid Res 34, 1583-1591
92. Gustafsson JA (1995) Fatty acid signalling of peroxisome proliferator-activated receptors. In: Peroxisomes, Biology and role in toxicology and diseases symposium. Aspen Co
93. Willson TM, Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for the nuclear peroxisome proliferator-activated receptor gamma. In: Peroxisomes, Biology and role in toxicology and disease symposium. Aspen Co & Ann NY Acad Sci, in press
94. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehman JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor g and promotes adipocyte differentiation. Cell 83, 813-819
95. Huang G, Alvares K, Chu R, Bradfield CA, Reddy JK (1994) Association of the peroxisome proliferator-activated receptor and Hsp72. J Biol Chem. 269, 8493-8497
96. Orellana A, Holingue L, Hidalgo PC, Faundez V, Gonzalez A, Bronfman M (1993) Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes. Eur J Biochem 215, 903-906
97. Orellana A, Hidalgo PC, Morales MN, Mezzano D, Bronfman M (1990) Palmitoyl-CoA and the acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate potentiate diacylglycerol-activated protein kinase C by decreasing the phosphatidylserine requirement of the enzyme. J Biochem 190, 57-61
98. Bennett A, Williams GM (1993) Calcium as a permissive factor but not an initiation factor in DNA synthesis induction in cultured rat hepatocytes by the peroxisome proliferator ciprofibrate. Biochem Pharmacol 46, 2219-2227
99. Hu E, Kim JB, Sarraf P, Spiegelman BM (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274, 2100-2103
100. Gebet T, Arand H, Oesch F (1992) Induction of the peroxisome proliferator-activated receptor by fenofibrate in rat liver. FEBS Lett 309, 37-40
101. Gearing KL, Crickmore A, Gustafsson JA (1994). Structure of the mouse peroxisome proliferator-activated receptor alpha gene. Biochem Biophys Res Commun 199, 255-263
102. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, Wahli N (1994) Regulation of the peroxisome proliferator-activated receptor a gene by glucocorticoids. J Biol Chem 269, 24527-24530
103. Steineger HH, Sörensen HN, Tugwood JD, Skrede S, Spydevold O, Gautvik KM (1994) Dexamethasone and insulin demonstrate marked and opposite regulation of the ready-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Eur J Biochem 225, 967-974
104. Lee SST, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Gonzalez FJ (1995) Targeted disruption of the a isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15, 3012-3022
105. Cohen AJ Grasso P (1981) Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man. Fd Cosmet Toxicol 19, 585-605
106. de la Iglesia FA, Lewis JE, Buchanan RA, Marcus EL, McMohen G (1982) Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis 43, 19-37
107. Hanfeld M, Kremer C, Kadner E (1983) Relation between morphological changes and lipid-lowering action of p-chlorophenoxy butyric acid (PIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 46, 239-246
108. Rodricks JV, Turnbull D (1987) Interspecies differences in peroxisomes and peroxisome proliferation. Toxicol Ind Health 3, 197-212
109. van Hoof F, Hue L, Vamecq J, Sheratt HSA (1985) Protection of rats by clofibrate against the hypoglycaemic and toxic effects of hypoglycin and pent-4-enoate. An ultrastructural and biochemical study. Biochem J 229, 387-397
110. Christophersen BO, Bremer J (1972) Erucic acid - an inhibitor of fatty acid oxidation in the rat. Biochim Biophys Acta 280, 506-514
111. Norseth J, Christiansen EN, Christophersen BO (1979) Increased chain shortening of erucic acid in perfused heart from rats fed rape-seed oil. FEBS Lett 97, 163-165
112. Christiansen RZ, Christiansen EN, Bremer J (1979) The stimulation of erucate metabolism in isolated rat hepatocytes by rapeseed oil and hydrogenated marine oil-containing diets. Biochim Biophys Acta 573, 417-429
113. Christiansen RZ, Osmundsen H, Borrebaek B, Bremer J (1978) The effect of clofibrate feeding on the metabolism of palmitate and erucate in isolated hepatocytes. Lipids 13, 487-491
114. Bioukar EB, Staehli F, Ng KH, Rolland MO, Hashimoto T, Carreau JP, Deschatrette J (1994) Resistance to erucic acid as a selectable marker for peroxisomal activity: isolation of revenants of an infantile refsum disease cell line. J Inh Metab Dis 17, 41-59
115. Stewart JM, Driedzic R, Berkelaar JAM (1991) Fatty acid-binding protein facilitates the diffusion of oleate in a model cytosol system. Biochem J 275, 569-573
116. Bass NM (1988) The cellular fatty acid binding proteins: aspects of structure, regulation and function. Int Rev Cytol 111, 143-184
117. Warner M, Neims AH (1975) Studies on Z-fraction. I. Isolation and partial characterization of low molecular weight ligand-binding protein from rat hepatic cytosol. Can J Physiol Pharmacol 53, 493-500
118. Glatz JF, Veerkamp JH (1983) A radiochemical procedure for the assay of fatty acid binding by proteins. Anal Biochem 132, 89-95
119. Haunerland N, Jagschies G, Schulenberg H, Spencer F (1984) Fatty-acid-binding proteins. Occurrence of two fatty acid-binding proteins in bovine liver cytosol and their binding of fatty acids, cholesterol and other lipophilic ligands. Hoppe-Seyler's Z Physiol Chem 365, 365-376
120. Schulenberg-Schell H, Schäfer P, Keuper HJK, Stanislawski B, Hoffman E, Rüterjans H, Spencer F (1988) Interaction of fatty acids with neutral fatty-acid-binding protein from bovine liver. Eur J Biochem 170, 565-574
121. Appelkvist EL, Dallner G (1980) Possible involvement of fatty acid binding protein in peroxisomal β-oxidation of fatty acid. Biochim Biophys Acta 617, 156-160
122. Tsukenoka M, Yamamoto A, Fujiki Y, Tashiro Y (1988) Non-specific lipid transfer protein (sterol carrier protein-2) is located in peroxisomes. J Biochem 104, 560-564
123. Knudsen J, Højrup P, Hansen HO, Hansen HF, Roepstorff P (1989) Acyl-CoA-binding protein in rat. Purification, binding characteristics, tissue concentrations and amino acid sequence. Biochem J 262, 513-519
124. Elholm M, Bjerking G, Knudsen J, Kristiansen K, Mandrup S (1996) Regulatory elements in the promoter region of the rat gene encoding the acyl-CoA-binding protein. Gene 173, 233-238
125. Palmer CNA, Hsu HH, Muerhoff AS, Griffin KJ, Johnson EF (1994) Interaction of the peroxisome proliferator-activated receptor a with the retinoid X receptor a unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1 binding site in the CYP4A6 promoter. J Biol Chem 269, 18083-18089
126. Chawla A, Lazar MA (1994) Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc Natl Acad Sci USA 91, 1786-1790
127. Tontonoz P, Hu E, Spiegelman BM (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147-1156
128. Kawashima Y, Horii S, Matsunaga T, Hirose A, Adachi T, Kozuka H (1989) Co-induction by peroxisome proliferators of microsomal 1-acylglycerophosphocholine acyl-transferase with peroxisomal β-oxidation in rat liver. Biochim Biophys Acta 1005, 123-129
129. Vu Dac N, Schoonjans K, Kosykh V, Dallongeville J, Fruchart JC, Staels B, Auwerx J (1995) Fibrates increase human human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest 96, 741-750
130. Casteels M, Schepers L, Van Eldere J, Eyssen HJ, Mannaerts GP (1988) Inhibition of 3α, 7α, 12α-trihydroxy-5-β-cholestanoic acid oxidation and of bile acid secretion in rat liver by fatty acids. J Biol Chem 263, 2654-2659
131. Wada F, Usami M (1977) Studies on fatty acid omega-oxidation. Antiketogenic effect and gluconeogenicity of dicarboxylic acids. Biochim Biophys Acta 487, 361-368
132. Kolvraa S, Gregersen N (1986) In vitro studies of the oxidation of medium-chain dicarboxylic acids in rat liver. Biochim Biophys Acta 876, 515-525
133. Draye JP, Vamecq J (1989) The gluconeogenicity of fatty acids in mammals (review). Trends Biochem Sci 14, 478-479
134. Vamecq J, Mestdagh N, Henichart JP, Poupaert J (1992) Subcellular distribution of glycolyltransferases in rodent liver and their significance in special reference to the synthesis of N-glycolyneuraminic acid. J Biochem 111, 579-583
135. Hayashi H, Takahata S (1991) Role of peroxisomal fatty acyl-CoA beta-oxidation in phospholipid biosynthesis. Arch Biochem Biophys 284, 326-331
136. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM (1995) PPARγ2 regulates adipose expression of the phosphoenol pyruvate carboxykinase gene. Mol Cell Biol 15, 351-357
137. Peters JM, Zhou YC, Rain PA, Lee SST, Gonzalez FJ, Waxman DJ (1996) Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta sulfate. Mol Pharmacol 50, 67-74
138. Bell RM, Coleman R (1980) Enzymes of glycerolipid synthesis in eukaryotes. Annu Rev Biochem 49, 459-487
139. James NH, Roberts RA (1996) Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. Carcinogenesis 17, 1623-1632
140. Kainu T, Wikström AC, Gustafsson JA, Pelto-Huikko M (1994) Localization of the peroxisome proliferator-activated receptor in the brain. NeuroReports 5, 2481-2485
141. Cherkaoui-Malki M, Lone YC, Corral-Debrinski M, Latruffe N (1990) Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators. Biochem Biophys Res Commun 173, 855-861
142. Khan SH, Sorof S (1994) Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc Natl Acad Sci USA 91, 848-852
143. Schoonjans K, Staels B, Auwerx J (1996) The peroxisome proliferator-activated receptor and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302, 93-100
144. Wu Z, Bucher NLR, Farmer SR (1996) Induction of the peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by c/EBPß, c/EBPδ and glucocorticoids. Mol Cell Biol 16, 4128-4136
145. Hu E, Tontonoz P, Spiegelman BM (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc Natl Acad Sci USA 92, 9856-9860
146. Devos P, Lefebvre AM, Miller SG, Guerremillo H, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J (1996) Thiazolidinediones repress Ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 98, 1004-1009
147. Jones PH, Powall HJ, Patsch W, Herd JA, Farmer, JA, Paytor-Ross C, Kimball KT, Gotto AM, Morrisett JD (1996) Effect of gemfibrozil on level of lipoprotein (a) in type II hyperlipoproteinic subjects. J Lipid Res 37, 1298-1308
148. Xing G, Zhang L, Zhang L, Heynen T, Yoshikawa T, Smith M, Weiss S, Detera-Wadleigh S (1995) Rat PPARδ contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei. Biochem Biophys Res Commun 217, 1015-1025
149. Huan B, Kosovsky MJ, Siddiqui A (1995) Retinoid X receptor α transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor. J Virol 69, 547-551
150. Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A (1995) Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoic and peroxisome proliferator signaling pathways. Proc Natl Acad Sci USA 92, 7401-7405
151. Wan YJ, Morimoto H, Thurman RG, Bojes HK, French SW (1995) Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci 56, 307-317
152. Pineau T, Hudgins WR, Liu L, Chen LC, Sher T, Gonzalez FJ, Samid D (1996) Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogue. Biochem Pharmacol 52, 659-667
153. Corton JC, Bocos C, Moreno ES, Meritt A, Marsmann DS, Jansen PJ, Cattley RC, Gustafsson JA (1996) Rat 17β hydroxysteroid dehydrogenase type IV is a novel peroxisome proliferator-inducible gene. Mol Pharmacol 50, 1157-1166
154. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, Wahli W, Grimaldi P, Staels B, Yamamoto T, Auwerx J (1995) Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 270, 19269-19276
155. Schoonjans K, Staels B, Grimaldi P, Auwerx J (1993) Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation. Eur J Biochem 216, 615-622
156. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP (1994) The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91, 11012-11016
157. Miller CW, Ntambi JM (1996) Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc Natl Acad Sci USA 93, 9443-9448
158. Hertz R, Bishara-Shieban J, Bar-Tana J (1995) Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J Biol Chem 270, 13470-13475
159. Zhang B, Berger J, Zhou GC, Elbrecht A, Biswas S, White-Carrington S, Szalkowski D, Moller DE (1996) Insulin and mitogen-activated protein kinase mediated phosphorylation and activation of peroxisome proliferator activated receptor gamma. J Biol Chem 271, 31771-31774
160. Adams M, Reginato MJ, Shao DL, Lazar MA, Chatterjee VK (1997) Transcriptional activation by peroxisome proliferator activited receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272, 5128-5132
161. Shalev A, Siegrist-Kaiser CA, Yen PM, Wahli W, Burger AG, Chin WW, Meier CA (1996) The peroxisome proliferator activated receptor α is a
162. Tontonaz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CDM, Brun RP, Muller E, Altiok S, Oppenheim H, Evans RM, Spiegelman BM (1997) Terminal differentiation of liposarcoma cells induced by ligands of peroxisome proliferator-activited receptor gamma and the retinoid receptor. Proc Natl Acad Sci USA 94, 237-241